Global Flavonoid Market Size Study & Forecast, by Product Type (Isoflavones, Anthocyanin, Others), By Form (Powder, Liquid), By Application (Nutraceuticals, Pharmaceuticals, Cosmetics, Food & Beverages), and Regional Analysis, 2023-2030

Global Flavonoid Market Size Study & Forecast, by Product Type (Isoflavones, Anthocyanin, Others), By Form (Powder, Liquid), By Application (Nutraceuticals, Pharmaceuticals, Cosmetics, Food & Beverages), and Regional Analysis, 2023-2030

Global Flavonoid Market is valued approximately at USD 1.69 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 6.2% over the forecast period 2023-2030. Flavonoids are a type of lower-level polyphenolic metabolites derived from plants and are consumed as dietary food that offers antioxidant properties. The pigments or colors in fruits, vegetables, and flowers are largely due to them. These colors help plants resist environmental stress UV radiation, cold stress, salt stress, etc. due to their high antioxidant content. Additionally, flavonoids are industrially produced, mostly in the form of isoflavones, anthocyanins, and other product kinds. Additionally, it is often utilized to treat conditions such as arthritis, cancer, cardiovascular disease, obesity, and hypertension. It is frequently used in the pharmaceutical and nutraceutical industries for tablets, supplements, and capsules. The rising awareness of the health benefits of flavonoids, rising inclination towards natural and herbal products, surging demand for functional foods and beverages, escalating geriatric population, the increasing investments in research and development are the key factors that are fostering the market demand across the globe.

In addition, the rising adoption of flavonoids in the nutraceuticals industry is also playing a major role that is stipulating the market growth during the estimated period. Flavonoids are gaining high traction across the nutraceuticals industry owing to the high demand and consumption of nutraceutical supplements containing flavonoids including anthocyanidins and isoflavones. According to Statista, the global nutraceuticals sector was worth USD 383.06 billion approximately, which is anticipated to reach USD 561.36 billion by the end of 2023. Flavonoids aid in the treatment of viral infections, diabetes, certain cardiac diseases, and other illnesses. Accordingly, the aforementioned factors have influenced the adoption of flavonoids such as anthocyanidins and isoflavones nutraceutical sector, which, in turn, fuel the expansion of the global flavonoid market. Moreover, the increase in the adoption of flavonoids in the food industry, as well as the introduction of dietary supplements in the untapped market present various lucrative opportunities over the forecast years. However, the availability of substitutes and the side effects of some flavonoids are hampering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Flavonoid Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 holding the largest market share owing to the changing consumer lifestyles, rising prevalence of various chronic ailments and growing awareness of the health benefits of flavonoids. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The growing demand for dietary supplements among the population, rising popularity of sports, along with the increasing disposable income are significantly propelling the market demand across the region.

Major market players included in this report are:
Archer Daniels Midland Company
Artemis International
BASF SE
Eevia Health Plc
Enomark Biotech (Enomark Healthcare)
Givaudan International Sa (Naturex S.A.)
Indena S.P.A.
Natac A/S
Nexira S.A.
Xian Yuensun Biological Technology Co., Ltd

Recent Developments in the Market:
In September 2022, Layn Natural Ingredients, a US-based company, unveiled bio+quercetin, a natural antioxidant flavonoid. The new product was marketed by the manufacturer as a highly bioavailable version of quercetin for nutraceutical usage. The Sophora japonica-derived flavonoid was developed to aid the industry in the transition to bioavailable goods.

In February 2022, Taiyo announced the availability of Sunactive IsoQ, a water-soluble precursor to quercetin that is made from isoquercitrin and has essentially higher bioavailability. This is a brand-new line of enhanced flavonoids.

In January 2022, Lantana Bio- the French company, and Biosyntia- the Danish biotech firm revealed their joint ambitions to accelerate the development of sustainable flavonoids for use in dietary supplements, food and beverage fortification, and cosmetics.

Global Flavonoid Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product Type, Form, Application, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Product Type:
Isoflavones
Anthocyanin
Others

By Form:
Powder
Liquid

By Application:
Nutraceuticals
Pharmaceuticals
Cosmetics
Food & Beverages

By Region:
North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa


Companies
Archer Daniels Midland Company
Artemis International
BASF SE
Eevia Health Plc
Enomark Biotech (Enomark Healthcare)
Givaudan International Sa (Naturex S.A.)
Indena S.P.A.
Natac A/S
Nexira S.A.
Xian Yuensun Biological Technology Co., Ltd

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.